Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Shikonin, a small molecule, speeds up skin wound healing in mice.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Topical treatments like AHAs, BHAs, and urea may help keratosis pilaris, but evidence is limited.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Gene expression, especially Dkk4, is key to cat color patterns.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Current treatments for keratosis pilaris provide temporary relief, but more research is needed for better solutions.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

A patient with complete hair loss regrew all her hair using tofacitinib.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Rumex japonicus extract may promote hair growth more effectively than Minoxidil.

Cis-UCA can form new compounds without enzymes, and sulphide donors reduce its UVB-induced toxicity in skin cells.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Kenikir leaf extract nanosuspension may help inhibit breast cancer cell growth.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Akkermansia muciniphila may help prevent testosterone-related hair loss.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.